Global Microbiome Sequencing Services Market Research Report 2022

Market Analysis and Insights: Global Microbiome Sequencing Services Market
The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services.
The global Microbiome Sequencing Services market size is projected to reach US$ 2288.3 million by 2028, from US$ 730.8 million in 2021, at a CAGR of 17.2% during 2022-2028.
The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market in 2016.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microbiome Sequencing Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microbiome Sequencing Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microbiome Sequencing Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microbiome Sequencing Services market.
Global Microbiome Sequencing Services Scope and Market Size
Microbiome Sequencing Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Microbiome Sequencing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sequencing By Synthesis
Sequencing By Ligation
Sanger Sequencing
Segment by Application
Pharmaceuticals
Biotech Companies
Academic
Authorities
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Baseclear
Clinical-Microbiomics
Molzym
Zymo Research
Rancho Biosciences
Microbiome Therapeutics
Microbiome Insights
Openbiome
Resphera Biosciences
Metabiomics
Ubiome
Shanghai Realbio Technology
Diversigen
Merieux Nutrisciences

Frequently Asked Questions